University of Birmingham researchers may have found a way to halt the Hepatitis C virus (HCV) that causes liver failure in 95% of transplant patients.
Re-infection of transplanted livers with the HCV virus can irreparably damage the new organ.
The research team headed up by Professor Jane McKeating, Professor David Mutimer and Dr Ian Rowe have demonstrated that, if HCV can be stopped by a drug which blocks the virus entering the liver, the chances of the liver transplant being a success is greatly improved.
Read published article
The research team headed up by Professor Jane McKeating, Professor David Mutimer and Dr Ian Rowe have demonstrated that, if HCV can be stopped by a drug which blocks the virus entering the liver, the chances of the liver transplant being a success is greatly improved.
Read published article
No comments:
Post a Comment